0001567619-21-001493.txt : 20210126 0001567619-21-001493.hdr.sgml : 20210126 20210126121621 ACCESSION NUMBER: 0001567619-21-001493 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210126 DATE AS OF CHANGE: 20210126 EFFECTIVENESS DATE: 20210126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Centrexion Therapeutics Corp CENTRAL INDEX KEY: 0001592052 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320402377 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-387332 FILM NUMBER: 21552529 BUSINESS ADDRESS: STREET 1: 200 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: (617) 837-6911 MAIL ADDRESS: STREET 1: 200 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Centrexion Corp DATE OF NAME CHANGE: 20131114 D 1 primary_doc.xml X0708 D LIVE 0001592052 Centrexion Therapeutics Corp 200 STATE STREET 6TH FLOOR BOSTON MA MASSACHUSETTS 02109 617-837-6911 DELAWARE None Centrexion Corp Corporation true Jeffrey B. Kindler 200 STATE STREET, 6TH FLOOR BOSTON MA MASSACHUSETTS 02109 Executive Officer Director James N. Campbell 200 STATE STREET, 6TH FLOOR BOSTON MA MASSACHUSETTS 02109 Executive Officer Director Randall M. Stevens 200 STATE STREET, 6TH FLOOR BOSTON MA MASSACHUSETTS 02109 Executive Officer Michael J. Ward 200 STATE STREET, 6TH FLOOR BOSTON MA MASSACHUSETTS 02109 Executive Officer Sol Barer 200 STATE STREET, 6TH FLOOR BOSTON MA MASSACHUSETTS 02109 Director Daniel Mendelson 200 STATE STREET, 6TH FLOOR BOSTON MA MASSACHUSETTS 02109 Director Sara Nayeem 200 STATE STREET, 6TH FLOOR BOSTON MA MASSACHUSETTS 02109 Director Joseph R. Swedish 200 STATE STREET, 6TH FLOOR BOSTON MA MASSACHUSETTS 02109 Director Shawn Tomasello 200 STATE STREET, 6TH FLOOR BOSTON MA MASSACHUSETTS 02109 Director Stella Xu 200 STATE STREET, 6TH FLOOR BOSTON MA MASSACHUSETTS 02109 Director Biotechnology Decline to Disclose 06b false 2021-01-12 false true true false 0 Maxim Group LLC 120708 None None 405 Lexington Avenue New York NY NEW YORK 10174 All States false 13500000 13500000 0 false 17 0 945000 true The compensation payable to the finder (Maxim Group LLC) consisted of a cash fee (listed above) plus the issuance of a warrant to purchase 96,076 shares of common stock. 0 false Centrexion Therapeutics Corp /s/ Michael Ward Michael Ward Chief Financial Officer, Treasurer and Secretary 2021-01-22